Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 7.998% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) Cc1ccc(OCCOC(=O)Cn2nc(C)c([N+](=O)[O-])c2C)cc1
(b) Cc1ccc(-n2nnc3c(SCC(=O)NCc4ccco4)ncnc32)cc1
(c) CC(=O)Nc1cccc(NC(=O)COC(=O)CO/N=C(\C)c2ccc3c(c2)OCO3)c1
Answer: b. Cc1ccc(-n2nnc3c(SCC(=O)NCc4ccco4)ncnc32)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(-n2nnc3c(SCC(=O)NCc4ccco4)ncnc32)cc1
Cc1ccc(-n2nnc3c(SCC(=O)NCc4ccco4)ncnc32)cc1
N-(furan-2-ylmethyl)-2-[3-(4-methylphenyl)triazolo[4,5-d]pyrimidin-7-yl]sulfanylacetamide